Insiders · Profile

Myles David C.

CH. DISCOV. & NON-CLIN DEV OFF at Olema Pharmaceuticals. Filing since 10 Dec 2021. CIK 0001831216

Company
Date
Role
Action
Shares
Amount
Of holding
14 Jan 2026
CH. DISCOV. & NON-CLIN DEV OFF
Sold at will
50,000
$1.44M
8.4%
13 Jan 2026
CH. DISCOV. & NON-CLIN DEV OFF
Sold at will
50,000
$1.38M
8.4%
12 Jan 2026
CH. DISCOV. & NON-CLIN DEV OFF
Sold at will
10,000
$283.40K
6.5%
19 Dec 2025
CH. DISCOV. & NON-CLIN DEV OFF
Sold at will
51,000
$1.55M
8.5%
11 Dec 2024
CH. DISCOV. & NON-CLIN DEV OFF
Sold at will
13,614
$118.12K
2.2%
10 Dec 2024
CH. DISCOV. & NON-CLIN DEV OFF
Sold at will
12,452
$116.80K
2.0%
22 Nov 2023
CH. DISCOV. & NON-CLIN DEV OFF
Sold at will
6,653
$92.41K
1.1%
21 Nov 2023
CH. DISCOV. & NON-CLIN DEV OFF
Sold at will
6,976
$103.82K
1.2%
8 Nov 2023
CH. DISCOV. & NON-CLIN DEV OFF
Sold on a plan
200
$3.52K
0.0%
3 Nov 2023
CH. DISCOV. & NON-CLIN DEV OFF
Sold on a plan
541
$9.47K
0.1%
2 Nov 2023
CH. DISCOV. & NON-CLIN DEV OFF
Sold on a plan
3,332
$51.18K
0.6%
1 Nov 2023
CH. DISCOV. & NON-CLIN DEV OFF
Sold on a plan
6,668
$100.15K
1.2%
19 Sep 2023
CH. DISCOV. & NON-CLIN DEV OFF
Sold on a plan
20,000
$253.40K
3.4%
10 Dec 2021
CHIEF DEVELOPMENT OFFICER
Sold, plan not stated
10,000
$103.00K
1.7%
14 decisions on file.